Events Search and Views Navigation
September 2021
Magnus Corfitzen CEO at Ascelia Pharma will present at HC Andersen Capital
Magnus Corfitzen will present Oncoral and the collaboration agreement with Taiho Oncology Inc. https://hcandersencapital.dk/event/ascelia-pharma-oncoral-samarbejde-med-det-amerikansk-baserede-taiho-oncology/
Find out more »Chief Medical Officer Carl Bjartmar will present Ascelia Pharma at Aktiespararna in Lund
For more information: Aktiedagen Lund 28 september | Aktiespararna Take the opportunity to ask your questions by sending a text message to 079-347 98 45 or emailing event@aktiespararna.se. Your questions will be conveyed by the moderator.
Find out more »Magnus Corfitzen CEO at Ascelia Pharma will present at Erik Penser Bank Orphan Drugs’s Day
Magnus Corfitzen will present at the Erik Penser Bank Orphan Drugs Day.
Find out more »October 2021
Danske Bank Event Series: Life Science, Launch Phase
Ascelia Pharma's CEO Magnus Corfitzen will present at Danske Bank Life Science Event Series.
Find out more »November 2021
Interim report 9M (January-September 2021)
Report will be released at 8.00am CET and conference call at 10.00am CET
Find out more »Danske Bank’s Winter Seminar
Ascelia Pharma’s CEO Magnus Corfitzen will present at Danske Bank's Winter Seminar.
Find out more »February 2022
Full year report 2021 (January-December 2021)
Report will be released at 8.00am CET and conference call at 10.00am CET
Find out more »May 2022
Annual General Meeting 2022
Annual General Meeting 2022
Find out more »Interim Report Q1 2022
Report will be released at 08:00am CET and conference call at 10:00am CET
Find out more »August 2022
Half-year report 2022
Report will be released at 08:00am CET and conference call at 10:00am CET
Find out more »
